Group 4 Question 4.docx

  • Uploaded by: rafael514
  • 0
  • 0
  • June 2020
  • PDF

This document was uploaded by user and they confirmed that they have the permission to share it. If you are author or own the copyright of this book, please report to us by using this DMCA report form. Report DMCA


Overview

Download & View Group 4 Question 4.docx as PDF for free.

More details

  • Words: 137
  • Pages: 1
Treatment: Specific therapy of bacterial conjunctivitis depends on identification of the microbiologic agent. While waiting for laboratory reports.      

Physician can start topical therapy with a broad-spectrum antibacterial agent (eg, polymyxin trimethoprim) In any purulent conjunctivitis in which the Gram stain shows gram-negative diplococci suggestive of neisseria, both systemic and topical therapy should be started immediately. If there is no corneal involvement, a single intramuscular dose of ceftriaxone, 1 g, is usually adequate systemic therapy. If there is corneal involvement, a 5-day course of parenteral ceftriaxone, 1–2 g daily, is required. In purulent and mucopurulent conjunctivitis, the conjunctival sac should be irrigated with saline solution as necessary to remove the conjunctival secretions. To prevent spread of the disease, the patient and family should be instructed to give special attention to personal hygiene.

Related Documents

Question 4
November 2019 8
Question 4
July 2020 10
Chapter 4 Question 4
June 2020 7
Group-4
December 2019 15

More Documents from ""